Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
暂无分享,去创建一个
Jiafu Ji | Suet Yi Leung | Xin Chen | Xin Chen | J. Ji | S. Leung | S. Yuen | A. S. Chan | W. Tsui | Coral Ho | Coral Ho | D. Guo | Ji Zhang | Siu Tsan Yuen | Dong Li Guo | Ji Zhang | Wai Yin Tsui | Annie S Y Chan | Annie S. Y. Chan
[1] D. Botstein,et al. Variation in gene expression patterns in human gastric cancers. , 2003, Molecular biology of the cell.
[2] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[3] Stephen W. Wilson,et al. Eph/Ephrin Signaling Regulates the Mesenchymal-to-Epithelial Transition of the Paraxial Mesoderm during Somite Morphogenesis , 2003, Current Biology.
[4] S. Tsugane,et al. Genomic structure and loss of heterozygosity of EPHB2 in colorectal cancer. , 2001, Cancer letters.
[5] J. Guan,et al. Inhibition of Integrin-mediated Cell Adhesion but Not Directional Cell Migration Requires Catalytic Activity of EphB3 Receptor Tyrosine Kinase , 2005, Journal of Biological Chemistry.
[6] M. Berens,et al. The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. , 2004, Cancer research.
[7] Ian P Newton,et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. , 2004, Genes & development.
[8] Elena B Pasquale,et al. EphB Receptor-binding Peptides Identified by Phage Display Enable Design of an Antagonist with Ephrin-like Affinity* , 2005, Journal of Biological Chemistry.
[9] T. Pawson,et al. Downregulation of the Ras–Mitogen-Activated Protein Kinase Pathway by the EphB2 Receptor Tyrosine Kinase Is Required for Ephrin-Induced Neurite Retraction , 2001, Molecular and Cellular Biology.
[10] Pauline Chu,et al. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] Paul Polakis,et al. EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer , 2004, Cancer Research.
[12] E. Pasquale,et al. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor , 2001, Oncogene.
[13] E. Pasquale,et al. Eph receptors and ephrin ligands: embryogenesis to tumorigenesis , 2000, Oncogene.
[14] William Ng,et al. Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening. , 2005, Journal of medicinal chemistry.
[15] H Sugimura,et al. Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors. , 1994, Cancer research.
[16] T. Pawson,et al. EphB receptor activity suppresses colorectal cancer progression (vol 435, pg 1126, 2005) , 2005 .
[17] A. Flahault,et al. Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression , 2003, Virchows Archiv.
[18] Tony Pawson,et al. β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinB , 2002, Cell.
[19] Tony Pawson,et al. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer , 2004, Nature Genetics.
[20] T. Pawson,et al. EphB receptor activity suppresses colorectal cancer progression , 2005, Nature.
[21] Hans Clevers,et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. , 2002, Cell.
[22] S. So,et al. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma , 2003, Oncogene.
[23] J. Frisén,et al. Ephrins are not only unattractive , 2002, Trends in Neurosciences.
[24] H. Sugimura,et al. Identification of protein-tyrosine kinase genes preferentially expressed in embryo stomach and gastric cancer. , 1993, Biochemical and biophysical research communications.
[25] H. Grabsch,et al. EphB2 is a Prognostic Factor in Colorectal Cancer , 2005, Clinical Cancer Research.
[26] Elena B. Pasquale,et al. The Eph family: a multitude of receptors that mediate cell recognition signals , 1997, Cell and Tissue Research.
[27] G. Yancopoulos,et al. EphB ligand, ephrinB2, suppresses the VEGF‐ and angiopoietin‐1‐induced Ras/mitogen‐activated protein kinase pathway in venous endothelial cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] J. Nesland,et al. Expression of Ephb2 and Ephb4 in breast carcinoma , 2008, Pathology & Oncology Research.
[29] L. Ellis,et al. Coexpression of ephrin‐Bs and their receptors in colon carcinoma , 2002, Cancer.
[30] Bert Vogelstein,et al. APC mutations occur early during colorectal tumorigenesis , 1992, Nature.